Transcranial Magnetic Stimulation (TMS)

Accelerated TMS Guided by Individualized fMRI Connectivity Targeting Outperformed Conventional Targeting in Major Depression Patients
A clinical trial led by BBRF grantee and prizewinner Joseph J. Taylor M.D., Ph.D., of Harvard and Mass General Brigham, has generated head-to-head evidence that neuroimaging can be used to improve… Read More
In Clinical Test, TMS Targeted Comorbid Depression and Anxiety Symptoms Separately, With Precision-Psychiatry Implications
Many psychiatric disorders are what doctors call “comorbid”—they co-occur with other disorders, whether other brain-based disorders or those affecting other parts of the body. Depression, for example… Read More
Personalized Accelerated TMS Therapy Targeting Brain’s Threat Circuity Significantly Reduced PTSD Symptoms
A clinical trial led by BBRF grantees has demonstrated for the first time that personalized targeting of non-invasive TMS brain stimulation therapy can reduce the brain’s reactivity to threat in… Read More
In Persisting Concussion Symptoms, a Perturbed ‘Core Network’ Is Identified, with Potential Targets for Non-Invasive Brain Stimulation Therapy
A significant number of people who suffer concussions—estimates range between 10% and 30%—experience a range of physical, cognitive, and emotional symptoms that persist for 4 or more weeks beyond the… Read More
Multiple Daily “Spaced” tDCS Stimulation Sessions Over 2 Weeks Helped Patients with Major Depression
Researchers led by 2019 BBRF Young Investigator Jean-Philippe Miron, M.D., Ph.D., have reported the first clinical test involving a new and more intensive way of delivering transcranial direct… Read More